These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5516752)

  • 41. Some biological characteristics of the mouse ascitic tumour NK-Ly passaged in AB-Jena-Gat.-Ko. strain mice.
    Seidlová A
    Neoplasma; 1969; 16(4):409-16. PubMed ID: 5344227
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of an in vitro strain of Ehrlich-Lettre ascites carcinoma subjected to many periodic mouse passages.
    Boone C; Sasaki M; McKee W
    J Natl Cancer Inst; 1965 Jun; 34(6):725-40. PubMed ID: 5829538
    [No Abstract]   [Full Text] [Related]  

  • 44. [2 types of polyribosomes in Ehrlich ascites carcinoma cells].
    Bukrinskaia AG; Nikolaeva OG; Grigor'eva MS; Zhdanov VM
    Dokl Akad Nauk SSSR; 1970; 194(6):1425-8. PubMed ID: 5493957
    [No Abstract]   [Full Text] [Related]  

  • 45. [Kinetic changes in the cellular proliferation of Ehrlich ascites tumor as affected by low-intensity laser radiation].
    Moskalik KG; Kozlov AP
    Tsitologiia; 1980 Dec; 22(12):1447-50. PubMed ID: 7210183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.
    Siems WG; Grune T; Schmidt H; Tikhonov YV; Pimenov AM
    Cancer Res; 1993 Nov; 53(21):5143-7. PubMed ID: 8221650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased polyamine concentration and tumor-derived lactate dehydrogenase activity in physiological fluids during regression of a heterologous tumor transplant.
    Andersson G; Bengtsson G; Albinsson A; Rosén S; Heby O
    Cancer Res; 1978 Nov; 38(11 Pt 1):3938-43. PubMed ID: 698943
    [No Abstract]   [Full Text] [Related]  

  • 48. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
    Ghosh S; Roy S; Banerjee M; Maity P
    J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biochemical characteristics of Ehrlich tumor Go-cells].
    Kavetskiĭ RE; Kaz'min SD
    Dokl Akad Nauk SSSR; 1976; 230(1):223-6. PubMed ID: 976046
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study of the correlation of radiation destruction of a tumor and its bed].
    Strelin GS; Shiffer IV; Bychkovskaia IB
    Med Radiol (Mosk); 1975 Jan; 20(1):55-7. PubMed ID: 1128196
    [No Abstract]   [Full Text] [Related]  

  • 51. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
    Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
    Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mitotic cycle of radiosensitive and radioresistant sub-lines of Ehrlich ascites carcinoma].
    Efimov ML; Kleĭnbok TS
    Radiobiologiia; 1974; 14(6):922-3. PubMed ID: 4450002
    [No Abstract]   [Full Text] [Related]  

  • 53. Variation of cell kinetic parameters in relation to the growth rate of the Ehrlich ascites tumor.
    Woo KB; Wiig KM; Brenkus LM
    Cell Tissue Kinet; 1975 Jul; 8(4):387-90. PubMed ID: 1170949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antitumor effect of low-intensity extremely high-frequency electromagnetic radiation on a model of solid Ehrlich carcinoma].
    Gapeev AB; Shved DM; Mikhaĭlik EN; Korystov IuN; Levitman MKh; Shaposhnikova VV; Sadovnikov VB; Alekhin AI; Goncharov NG; Chemeris NK
    Biofizika; 2009; 54(6):1128-36. PubMed ID: 20067195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Proceedings: Peritoneal implantation and resorption of Ehrlich ascites carcinoma from the abdominal cavity -- scanning electron microscopy].
    Richter IE; Wildenhof H; Remmele W
    Verh Dtsch Ges Pathol; 1974; 58():505. PubMed ID: 4460526
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cytogenetic characteristics of the growth cycle of Ehrlich ascites tumor].
    Efimov ML; Voĭtovitskiĭ VK
    Tsitologiia; 1966; 8(3):423-7. PubMed ID: 5984096
    [No Abstract]   [Full Text] [Related]  

  • 57. [Course of mammary carcinoma. New immunopathological parameters of evaluation. Experimental study in mice (MuMT). III--Ascitic fluid].
    Behmer OA; Zanotto A; Castro de Tolosa EM; do Nascimento JJ; da Silva RG
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):4-7. PubMed ID: 3423602
    [No Abstract]   [Full Text] [Related]  

  • 58. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
    Dobaczewska H
    Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The contribution of the scanning electron microscope to studies on the influence of chemotherapeutics on NK/Ly ascites lymphoma.
    Kurnatowski A; Hajdukiewicz G; Hajdukiewicz Z; Karasek M
    Ann Med Sect Pol Acad Sci; 1974; 19(2):125-7. PubMed ID: 4141828
    [No Abstract]   [Full Text] [Related]  

  • 60. Inducible NO synthase inhibits the growth of free tumor cells, but enhances the growth of solid tumors.
    Nishikawa M; Chang B; Inoue M
    Carcinogenesis; 2004 Nov; 25(11):2101-5. PubMed ID: 15205363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.